JPS59204122A - 人の悪性腫瘍細胞増殖抑制剤の製造方法 - Google Patents

人の悪性腫瘍細胞増殖抑制剤の製造方法

Info

Publication number
JPS59204122A
JPS59204122A JP58078300A JP7830083A JPS59204122A JP S59204122 A JPS59204122 A JP S59204122A JP 58078300 A JP58078300 A JP 58078300A JP 7830083 A JP7830083 A JP 7830083A JP S59204122 A JPS59204122 A JP S59204122A
Authority
JP
Japan
Prior art keywords
malignant tumor
animal
medium
tumor cell
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58078300A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0472807B2 (https=
Inventor
Tomoyuki Tajima
知行 田島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP58078300A priority Critical patent/JPS59204122A/ja
Priority to US06/583,011 priority patent/US4595657A/en
Priority to EP84303035A priority patent/EP0125125A3/en
Publication of JPS59204122A publication Critical patent/JPS59204122A/ja
Publication of JPH0472807B2 publication Critical patent/JPH0472807B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58078300A 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法 Granted JPS59204122A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58078300A JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法
US06/583,011 US4595657A (en) 1983-05-06 1984-02-23 Process for preparing an inhibiting agent against proliferation of animals malignant tumor cells
EP84303035A EP0125125A3 (en) 1983-05-06 1984-05-04 An agent for inhibiting the proliferation of malignant tumour cells and a process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58078300A JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法

Publications (2)

Publication Number Publication Date
JPS59204122A true JPS59204122A (ja) 1984-11-19
JPH0472807B2 JPH0472807B2 (https=) 1992-11-19

Family

ID=13658070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58078300A Granted JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法

Country Status (3)

Country Link
US (1) US4595657A (https=)
EP (1) EP0125125A3 (https=)
JP (1) JPS59204122A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法
JPS6028931A (ja) * 1983-07-28 1985-02-14 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
JP2004155670A (ja) * 2002-11-01 2004-06-03 Youichirou Naganushi 細胞賦活剤、細胞賦活剤製造方法及びその装置
RU2283654C1 (ru) * 2005-03-30 2006-09-20 Борис Владимирович Афанасьев Способ получения ростовых факторов белковой природы, ростовой фактор белковой природы и ингибитор пролиферации фибробластов

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
FR2302747B1 (fr) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med Procede d'obtention, a partir de macrophages de mammiferes, d'un produit therapeutique actif, notamment, a l'egard des cellules tumorales humaines et produit therapeutique ainsi obtenu
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法

Also Published As

Publication number Publication date
JPH0472807B2 (https=) 1992-11-19
US4595657A (en) 1986-06-17
EP0125125A2 (en) 1984-11-14
EP0125125A3 (en) 1986-10-08

Similar Documents

Publication Publication Date Title
Bernfield Collagen synthesis during epitheliomesenchymal interactions
US4793996A (en) Method of making soybean extract inhibitor
EP0102801B1 (en) An agent for inhibiting proliferation of malignant tumour cells
JPS59204122A (ja) 人の悪性腫瘍細胞増殖抑制剤の製造方法
CN101250572A (zh) 一种提取猪血抗菌肽的方法
KR102563616B1 (ko) 줄기세포 유래 수용성 세포외기질 및 이의 제조방법
CN101294172A (zh) 一种米糠中γ-氨基丁酸(GABA)的生物富集法
CN104087640A (zh) 一种利于皮肤或粘膜吸收的鹿茸多肽系列提取方法
DE3226320C2 (https=)
Sado Functional and Ultrastructural Studies of Antibody-producing Cells Exposed to 10 000 R in Millipore Diffusion Chambers
EP0118286B1 (en) Process for preparing an inhibiting agent
JPH0361650B2 (https=)
Price et al. Effect of fractions of horse and fetal bovine serum on neoplastic conversion of C3H mouse cells in tissue culture
FR2586699A1 (fr) Fractions de lait, procede d'obtention de ces fractions et milieux de cultures cellulaires renfermant ces fractions
JPS6028931A (ja) ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
CN114908057A (zh) 一种以工程化红细胞作为滋养层细胞体外高效扩增nk细胞的方法
JPH0361648B2 (https=)
JPH06169761A (ja) 動物由来線維芽細胞の無血清培養用培地及び培養方法
JPS603827B2 (ja) 細胞培養方法
JPH0244515B2 (https=)
JP3088680B2 (ja) 腸内菌、レイ菌による抗腫瘍物質の合成法
CN121243351A (zh) 一种治疗过敏性皮肤炎症的干细胞因子复合药物组合物及其制备方法
JPH01265029A (ja) 人の悪性腫瘍細胞増殖抑制剤
JPH02117687A (ja) 甘草由来細胞賦活作用剤
KR20230146950A (ko) 엑소좀 분비 촉진용 조성물 및 이의 용도